chemical assay of drugs and drug metabolites
TRANSCRIPT
![Page 1: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/1.jpg)
Chemical Assay of Drugs and Drug
Metabolites
Sanford P. Markey
Laboratory of Neurotoxicology
NIMH
September 12, 2013
![Page 2: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/2.jpg)
Lecture Outline
• Quantification principles
– Analytical PK lab tasks
• Chromatography
• Detection - spectroscopies
– Optical
– Mass
• Examples
– Vorapaxar
– Antiviral nucleoside - microdosing
– CYP450 Assays
– Cyclosporin A
– Moxifloxacin
• References 2
![Page 3: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/3.jpg)
Definition of Analytical Terms
• Limits of detection (LOD)
– Sensitivity is the minimum detectable concentration change that can be observed at a specified concentration
– LOD is the minimum mass or concentration of analyte that can be detected at an acceptable signal to noise (S/N) ratio
• Lower limits of quantification (LLOQ)
– Analyte mass or concentration required to give an acceptable level of confidence in the measured analyte quantity
– Always greater (usually 3x) than the minimum LOD
• Selectivity is the ability of an analytical method to differentiate and quantify the analyte in the presence of other components in the sample
3
![Page 4: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/4.jpg)
Accuracy vs. Precision
Good accuracy
Poor precision
Poor accuracy
Good precision
Good accuracy
Good precision
4
![Page 5: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/5.jpg)
Pharmaceutical Industry PK Lab
Analytical Assays (1)
• Parent drug usually the target analyte for Phase 1 dose response and safety determinations
• Scale of runs: 30-50 samples/patient, plus 10-15 standards, procedural blanks, plus 10-15 QC pools or previously analyzed samples
• Several patients per run - effort to optimize patient/(standards + QC) ratio. Result is >100 samples/run
• Analytical runs require automation & rugged instrumentation, continuous operation for assay cycle time X number of samples
• Develop assays on 96 well or 384 well devices
5
![Page 6: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/6.jpg)
Pharmaceutical Industry PK Lab
Analytical Assays (2)
• Speed of assay development principal
determinant of methodology choice
– Avoid derivatization chemistry
– Use solid phase extraction or simple
methanol/acetonitrile protein precipitation
• Time is money (3 min UHPLC/MS/MS
assay vs. 40 min HPLC)
• First option: use automated
UHPLC/MS/MS methods with high
sensitivity and selectivity
6
![Page 7: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/7.jpg)
Assay Issues
• What to assay (what is important?)
– Species - • man, non-human primate, rat, mouse
(transgenic)
– Tissue/Fluid • liver, target organ, plasma, excreta
– Isolated organ/tissue fluids • liver slices, human liver microsomes, CYPs,
other enzymes
7
![Page 8: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/8.jpg)
Assay Issues
• Commercial Aides – Drug metabolizing preparations
• Human liver tissue or hepatocytes – all enzymes present in fresh (not frozen) tissue – single use only
• Microsomes from frozen liver; easily stored
• Recombinant CYPs and other enzymes - widely available (yeast, baculovirus, bacteria) and some mammalian cells with NADPH CYP reductase
• CYP substrates, antibodies, inhibitors, inducers
– Computer software - predict metabolites, pKa, pLogD, logP
– Contract Research Organizations
8
![Page 9: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/9.jpg)
Liquid Chromatography
• Most pharmaceuticals small molecules (<1000 Da)
with some lipid solubility, adsorb to silica particles
coated with stable organic hydrocarbon films
• A single analytical system can be used for many
types of analyses, tailored to each by changing the
solvents and gradients
• High Performance or High Pressure - HPLC
– 3-5 µm surface coated, hard particles
• 500-1000 psi pressures common
• 1-5 mm diameter, 10-15 cm length columns
– Reverse Phase - polarity separation
– Cation & Anion Exchange - charge separation
• Ultra High Pressure LC - higher performance
– 1-2 µm particle size
• 10,000-30,000 psi (thousands of atmospheres)
9
![Page 10: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/10.jpg)
Liquid Chromatography – simple principles
stationary
phase
column
mixture solvent
(eluent)
![Page 11: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/11.jpg)
column
detector
computer
controller
Pump A
Pump B
chromatogram
Liquid Chromatography – typical instrumentation
![Page 12: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/12.jpg)
Detection Principles (1)
• Ultraviolet or Fluorescence
Spectroscopy
– chromophore in drug or derivatized drug
– most useful for known target analytes
• Nuclear Magnetic Resonance
Spectrometry
– most useful for totally unknown chemical
structure characterization
– least sensitive
12
![Page 13: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/13.jpg)
grating
flow cell
reference detector
sample detector
light source
lens
monochromator
absorption spectrum
Absorption Spectrophotometer
![Page 14: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/14.jpg)
Emission Spectrophotometer
LightSource
Mono-chromator
Photo-detector
SampleRecorder
Mono-chromator
![Page 15: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/15.jpg)
Detection Principles (2)
• Mass Spectrometry – versatile ionization modes for liquids and gases
• electron, chemical, electrospray, desorption
– versatile mass analyzers with varying capabilities
• magnetic, ion trap, quadrupole, time-of-flight
• combination analyzers in series – triple quadrupole
– quadrupole-time-of-flight
– linear trap-orbitrap, etc, etc
– very sensitive and structurally informative –example: air, acetaminophen
– added specificity through mass chromatography • tandem mass chromatography = multiple reaction
monitoring 15
![Page 16: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/16.jpg)
Mass Analyzer Ionizer
Collision Region
2nd Mass Analyzer
Ion Detector
+
+ +
+
+ + +
+ +
+
+ + +
+ + +
High Vacuum Chamber
Computer Controller
Mass Spectrometer Component Overview
![Page 17: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/17.jpg)
M0 M+
repeller
trap
filament
mass analyzer
neutral molecule
odd electron positive ion
electron beam
acceleration lens
kV
high vacuum chamber
Mass Spectrometer Ionizers - Electron Ionization
![Page 18: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/18.jpg)
+kV capillary
mass analyzer (high vacuum)
vacuum interface
electrosprayed ions
drying gas
HPLC
Mass Spectrometer Ionizers -
Electrospray Ionization
![Page 19: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/19.jpg)
laser beam
matrix
extraction lens
neutral analytes
ablated area
positively charged analyte
ions
Mass Spectrometer Ionizers -
Martrix Assisted Laser Desorption Ionization (MALDI)
![Page 20: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/20.jpg)
ion inlet
acceleration lenses
Ion detector heavy
ions
light ions
vacuum chamber
Mass Analyzers: Time-of-Flight (TOF)
![Page 21: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/21.jpg)
+
+ -
- non-resonant ion
resonant ion
Ion source
Detector
Mass Analyzers: Quadrupole (q)
![Page 22: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/22.jpg)
ion beam entrance
resonant trapped ion cloud
detector
detector
Mass Analyzers: Linear trap quadrupole (LTQ)
Quad guide 1
Quad guide 3
Quadrupole 2 - trap and analyzer
![Page 23: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/23.jpg)
Mass Spectrum of Air
m/z
Relative
Intensity 18
28
40
44
32
H2O + °
O2
+ °
Ar + °
CO2
+ °
N2
+ °
![Page 24: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/24.jpg)
Mass spectrum of acetaminophen
(Electron Ionization)
![Page 25: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/25.jpg)
MS1 mass chromatograms
Total ion chromatogram
time
Signal intensity
MS1 spectra MS2 spectra
MH+
MH+ → fragment2
MH+ → fragment1
MS2 Selected Reaction Monitor
(SRM) chromatograms
Multi-dimensional anlyses
![Page 26: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/26.jpg)
Pharmaceutical Industry PK Lab Analytical Assay
Work Load for New Chemical Entities
Method 1990 1998 2000 2013
HPLC 75% 50-60% 20% 2%
GC/MS 12% 3% 2% 0
LC/MS/MS 3% 40-50% 60-75% 98%
RIA 10% 10% 10% 0
Preliminary lead
profile time 18 m 4 m 0 0
Conclusion: requirement for speed (not instrumentation cost)
dictates choice of analytical methods
![Page 27: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/27.jpg)
Methods for Qualitative & Quantitative Assays
in Clinical Pharmacology
• LC/MS/MS
– High speed, reduced requirement for sample preparation
• HPLC/UV or Fluorescence
– Very robust, routine assay technology
• Enzyme Linked Immunoassay (ELISA)
– Many 96 well formatted colorimetric or radiometric commercial assay kits for specific compounds
• Florescence polarization immunoassay (FPIA)
– Measures difference in florescence between bound and free antigen
– Important in therapeutic drug monitoring – CsA
• Accelerator Mass Spectrometry - microdosing 27
![Page 28: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/28.jpg)
Examples of Analytical Methods
Applied in Drug Analyses
• 1. Vorapaxar – UHPLC/MS/MS
• 2. Antiviral nucleoside - microdosing
• 3. CYP450 Assays - LC/MS/MS
• 4. Cyclosporin - FPIA, HPLC/UV, LC/MS/MS
– Dried Blood Spot technology
• 5. Moxifloxacin – imaging mass spectrometry
28
![Page 29: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/29.jpg)
493.1
476.0
447.0
404.4
429.3 403.3
MH+
Inte
nsity
m/z vorapaxar
MS/MS spectrum of 493
UHPLC-MS/MS Assays of New Chemical Entities
Tama CI, et al. Determination of a novel thrombin receptor antagonist (SCH 530348) in human plasma:
evaluation of Ultra Performance Liquid Chromatography-tandem mass spectrometry for routine
bioanalytical analysis. J Pharm Biomed Anal 2011; 55: 349-359.
46 Da
![Page 30: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/30.jpg)
Reproducible analyses at LLOQ
Black and blue traces
are runs #1 and #279
m/z 499 -> 453
![Page 31: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/31.jpg)
Example 2 -Where Do Drugs Go?
• Radiochemical tracers (14C, 3H)
– requires availability of labeled drug • useful for bioavailability, kinetics
• detection of protein adducts/localization (autoradiography)
– Specific atom or isotope detectors • Accelerator mass spectrometry (AMS) - detection
of 14C at near natural background levels for drug pharmacokinetics
• Ideal for human studies of toxic mechanisms - DNA
• Non-radiochemical methods • Unique drug elements (fluorine, etc.) or structural
property (fluorescence)
31
![Page 32: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/32.jpg)
Accelerator Mass Spectrometry - AMS
• Equipment is special – usually at national lab
resource, or central shared industrial facility
• Samples converted to elemental carbon- first to CO2,
then by reduction to carbon in sealed tubes (10 µL
plasma, 400 µg carbon required) ~1000 atoms 14C
– LLOD: 30 aCi/mg Carbon; 3 amoles agent/sample with 5%
precision
• Precise isotope ratio measured
12C:13C:14C for quantification
32
14C label Compound A
antiviral
Sandhu P, et al. Evaluation of microdosing strategies
for studies in preclinical drug development:
demonstration of linear pharmacokinetics in dogs of a
nucleoside analog over a 50-fold dose range. Drug
Metabolism and Disposition 2004; 32: 1254-1259.
![Page 33: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/33.jpg)
Microdose
0.02 mg/kg P.O.
Conventional
dose
1.0 mg/kg P.O.
AMS measurement
Sandhu P, et al. Drug Metabolism and Disposition 2004; 32: 1254-1259.
Total 14C measured by AMS
Parent levels measured by LC/MS/MS
![Page 34: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/34.jpg)
AMS - Microdosing • Can microdose studies in humans provide an early
measure of the pK properties of a NDE?
• Pharmacokinetics in the dog linear over a 50-fold
dose range for compound A
• European Microdosing AMS Partnership Programme
(EUMAPP) tested 7 drugs (2006-8)
– Drugs selected were problematic for pK predictive models
(eg in vitro and animal species)
– Conclusion: ‘Intravenous microdose data predicted t1/2 (half-
life), CL (clearance) and V (volume of distribution) very well.
Oral dose data did not scale as well as the IV dose but in
general, the data obtained would have been useful in the
selection of drug candidates for further development (or
dropped from the development pipeline).
34 Stenstrom K,et al. Microdosing for early biokinetic studies in humans.
Radiat Prot Dosimetry 2010; 139: 348-352.
![Page 35: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/35.jpg)
Example 3: LC/MS/MS CYP GLP Assays
• 12 Semi-automated assays for 10 human CYP450 enzymes described
• Microsomes pooled from 54 human livers • Microsomes, NADPH, substrate in 96 well plate; stable isotope
internal standards added with quenching solvent • Recombinant CYP450 enzymes (Sf9 cells) from PanVera run in
parallel; reference values published • High speed LC/MS/MS conditions established for each analyte
and internal standard (2 min/assay) • Interassay precision of reaction velocity <10% Validated Assays for Human Cytochrome P450 Activities, RL Walsky and
RS Obach, Drug Metab Disp 32:647-660, 2004
35
![Page 36: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/36.jpg)
CYP 450 Validated Assay Bupropion and hydroxy metabolite
m/z 256 139 262 139
From RL Walsky & RS Obach
multiple reaction monitoring
36
![Page 37: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/37.jpg)
Hydroxybupropion - ESI-MS
8 0 9 0 1 0 0 1 1 0 1 2 0 1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 2 5 0 2 6 0 2 7 0 m / z 0
1 0 0
%
MH+ 256
m/z
Int
[D6]-MH+ 262
From RL Walsky & RS Obach
+ [D6]-hydroxybupropion
![Page 38: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/38.jpg)
Hydroxybupropion - CID of MH+ 256
8 0 9 0 1 0 0 1 1 0 1 2 0 1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0 1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0 2 5 0 2 6 0 m / z 0
1 0 0
%
139
MH+ 256
m/z
Int
MH+ 262
From RL Walsky & RS Obach
[D6]-Hydroxybupropion - CID of MH+ 262
![Page 39: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/39.jpg)
Example: CYP2B6 Assay
Bupropion substrate
0
1 0 0
%
1 3
1 0 0
%
[D6]Hydroxybupropion
Hydroxybupropion
1.97 r.t.
628 area
1.96 r.t.
96538 area
256 139
262 139
retention time (min)
From RL Walsky & RS Obach
0.20 1.00 2.00 2.80
39
![Page 40: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/40.jpg)
Example: CYP2B6 Results
From RL Walsky & RS Obach 40
![Page 41: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/41.jpg)
Partial Summary of CYP Activities RL Walsky and RS Obach, Drug Metab Disp 32:647-660, 2004
Enzyme Assay Inhibitor IC50 (µM)
Human Recomb
CYP1A2 Phenacetin
O-deethylase Furafylline 1.76±0.28 1.54±0.16
CYP2A6 Coumarin 7-
hydroxylase
Tranylcyp-
romine 0.449±.073 0.895±.262
CYP2B6 Buproprion
hydroxylase PPP 7.74±0.47 2.02±0.19
CYP2C8 Amodiaquine
N-deethylase Quercetin 3.06±0.31 3.33±0.20
CYP2C9 Diclofenac 4’-
dydroxylase
Sulfaphen-
azole 0.272±.031 0.169±.004
41
![Page 42: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/42.jpg)
Example 4: Cyclosporin A (CsA)
• HPLC - UV (210 nm) method first used for clinical analyses – LOQ - 20-45 µg/L (therapeutic range 80-300 µg/L)
• LC/MS/MS method for fingerprick samples
– 25 µL; LOQ 10 µg/L
– Keevil BG, Ther Drug Monitor 24: 757-67 (2002)
Potent immunosuppresive drug
for transplantation; irreversible
kidney damage if dose too high
42
![Page 43: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/43.jpg)
Cyclosporin Immuno Assays
• Florescence polarization immunoassay (FPIA) – Homogeneous immunoassay – Fluorescein tagged drug competes with patient drug
for monoclonal Ab – Polarized light excites Ab-tagged drug complex most
efficiently – LOQ 25 µg/L; analysis of 20 samples in 19 min
• Enzyme monitored Immunoassay Technique (EMIT) and Cloned Enzyme Donor Immunoassay (CEDIA)
– Competitive: enzyme labeled antigen competes with sample antigen; enzyme labeled antigen-Ab complex changes rate
• Multiple cyclosporin metabolites exhibit cross-reactivity in immunoassays
43
![Page 44: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/44.jpg)
UPLC/MS/MS therapeutic drug monitoring
of immunosuppressants compared to
immunoassay
W. Tszyrsznic et al., J Chromatog B 928, 1 June 2013, 9–15
Immunoassay means ~30% higher than LC/MS/MS
![Page 45: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/45.jpg)
Dried Blood Spot vs Whole Blood Assay
for CsA assay by UHPLC-MS/MS
E. Hinchliffe, et al., J. Chromatogr. B (2012) 883-884:102-107
45
![Page 46: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/46.jpg)
Dried Blood Spots for pK and other
measurements
• For CsA, 6 mm discs punched using a stationery paper hole
punch, placed into 96-well plates, and ultrasonically extracted
using hot methanol in the presence of added internal standards
• 15 µL spots tested for acetaminophen toxicokinetic analysis in
dog - Barfield, J Chrom B 870:32-37 (2008)
• Variables noted for quantitative analyses - Spooner, Anal Chem
81: 1557-63 (2009)
• Photodegredation of light sensitive compounds less than
solution storage - Bowen, Bioanalysis 2:1823-8 (2010)
• Multiple commercial collection devices (paper, coated surfaces)
marketed
• Excellent review of Dried Blood Spot analysis and applications
by Demirev, Anal Chem 85(2)779-789 2013
46
![Page 47: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/47.jpg)
…………. …………. …………. …………. ………….
tissue slide matrix
application
…………. …………. …………. …………. ………….
laser
ablation/ionization
tandem
mass spectrometry
ms1 ms2
MS2 compound specific
histological images
array of MS1/MS2
spatial data
Example 5 – Tissue Imaging
![Page 48: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/48.jpg)
Imaging Mass Spectrometry – Drug Metabolism
Olanzapine (8 mg/kg, oral)
Distribution after 2 hr from
MS/MS images
Khatib-Shahidi, et al.
Anal Chem 2006;
78: 6448-6456.
48
![Page 49: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/49.jpg)
Imaging Mass Spectrometry – kinetics of moxifloxacin
distribution in lung
Prideaux et al. Anal Chem 2011; 83: 2112-2118.
Fluoroquinone anti-TB agent
49
![Page 50: Chemical Assay of Drugs and Drug Metabolites](https://reader030.vdocument.in/reader030/viewer/2022020706/61fca0859d50e757a521d210/html5/thumbnails/50.jpg)
Useful Reference Web Sites
• http://ull.chemistry.uakron.edu/classroom.html
– Excellent introductory tutorials in analytical
methods including chromatography and mass
spectrometry
• http://ionsource.com/
– Site with very useful links for mass spectrometry
including tutorials, freeware
• http://ocw.mit.edu/courses/#chemistry
• http://svmsl.chem.cmu.edu/vmsl/default.htm
– Virtual mass spectrometry laboratory with tutorial
and excellent case study examples
– In-depth course materials for chemistry
50